This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Esophagectomy is a surgical procedure to remove part or all of the esophagus, the tube that connects the throat to the stomach. The procedure is used to treat cancer in the esophagus as well as other conditions, such as a narrowing of the esophagus (stricture) or other blockage. Depending on the extent of the surgery and the patient’s overall health, the procedure can be done in a variety of ways and involve a variety of techniques. Open esophagectomy is the most common type of esophagectomy, and it involves a long incision in the upper chest and abdomen. The surgeon will then remove the cancerous or diseased portion of the esophagus, along with some of the tissue surrounding it. The remaining portion of the esophagus is then reattached to the stomach or small intestine. Robotic esophagectomy is a newer type of esophagectomy that is done with the help of a robotic system. The surgeon uses a small camera and robotic arms to perform the procedure, which can help reduce the risk of complications. Robotic surgery is still considered experimental, so it is not widely available. For both types of esophagectomies, the patient will typically be hospitalized for several days after the procedure. During this time, they will be given antibiotics to prevent infection, as well as medications to help ease pain and discomfort. After the surgery, the patient will need to follow a special diet for several weeks to give the esophagus time to heal. Generally, a full recovery can take up to three months.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States